Medical University of South Carolina | Strategic Alliance Partners

Lacy La Fever, PharmD, MS, discussed outcomes associated with different carboplatin AUC dosing strategies.

Lauren Dietz, PharmD, highlighted the role of oncology pharmacists in guiding prophylaxis decisions to optimize transplant outcomes.

The initiative will provide information about care models for specialists and clinical teams to improve patient outcomes in heart failure.

Cyclin-dependent kinase 4/6 (CDK 4/6) inhibitors have transformed the treatment of hormone receptor-positive/HER2-negative breast cancer across metastatic and early-stage settings, with ongoing research exploring their potential in additional breast cancer subtypes, combination therapies, and aggressive disease scenarios.

Pharmacists are encouraged to work closely with health care providers to ensure appropriate use of high-cost Intravenous immunoglobulin (IVIG) therapy for BK nephropathy.

Pharmacists can optimize IVIG treatment for BK nephropathy in kidney transplant recipients by educating providers and monitoring for infusion reactions.

Pharmacists are well-positioned to address diabetes from a multifaceted approach.

Two MUSC pharmacy technicians discuss how techs are pivotal in pharmacy, whether in the community or clinical setting, and how it is important to maintain high standard of care in a changing environment.

Simply stating a team member good job, whether it be within a group or in a 1-on-1 setting, 2 MUSC pharmacy technicians emphasize that recognition and encouragement go a long way.

Two MUSC pharmacists describe how pharmacists are often the educational resource for patients and can help when removing certain barriers to care.

This review explores cytopenia after CAR T-cell therapy, including its risk stratification and management with growth factors, thrombopoietin-receptor agonists, and hematopoietic stem cell boosts.

Using information from clinical studies and her experiences working in the field, Stephanie Kirk describes treatment options that are on the horizon, and how removing stigma is key in HIV care.

Expert explains how the role of pharmacists in myelofibrosis treatment has evolved significantly over the past decade.

Sheldon Litwin, MD, a cardiologist at the Medical University of South Carolina, discussed the significant recent advances in anti-obesity drugs.